Clinical Trials
2
Active:1
Completed:1
Trial Phases
2 Phases
Phase 1:1
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (50.0%)Phase 2
1 (50.0%)Effects of Tregalizumab on Allergen-induced Airway Responses and Airway Inflammation in Asthmatic Patients
Phase 2
Completed
- Conditions
- Allergy to House Dust MiteAllergic Asthma
- Interventions
- Other: Placebo
- First Posted Date
- 2020-12-17
- Last Posted Date
- 2022-02-08
- Lead Sponsor
- T-Balance Therapeutics GmbH
- Target Recruit Count
- 42
- Registration Number
- NCT04673591
- Locations
- 🇩🇪
Medaimun GmbH, Frankfurt, Germany
News
No news found